Traumatic brain injury: Oxidative stress and neuroprotection

Antioxidants and Redox Signaling

Volumn 19, Issue 8, 2013, Pages 836-853

  Cornelius, Carolin ^a,b   Crupi, Rosalia ^a   Calabrese, Vittorio ^b   Graziano, Antonio ^b   Milone, Pietro ^b   Pennisi, Giovanni ^b   Radak, Zsolt ^c   Calabrese, Edward J ^d   Cuzzocrea, Salvatore ^a,e  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARNITINE; CARNOSINE; CORTICOSTEROID; DEXANABINOL; ERYTHROPOIETIN; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GROWTH FACTOR; HEAT SHOCK PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON; MAGNESIUM SULFATE; MALONALDEHYDE; METHYLPHENIDATE; N ACETYLASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEGORGOTEIN; PEROXYNITRITE; PROGESTERONE; REACTIVE OXYGEN METABOLITE; RIVASTIGMINE; SCAVENGER; SIRTUIN; SUPEROXIDE DISMUTASE;

AGING; APOPTOSIS; BRAIN FUNCTION; BRAIN MITOCHONDRION; BRAIN NECROSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROTECTION; CELLULAR STRESS RESPONSE; CHEMICAL REACTION; COGNITION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA CLEAVAGE; DNA DAMAGE; DNA REPAIR; ENCEPHALITIS; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; EXCITOTOXICITY; GENE EXPRESSION; HEAT SHOCK RESPONSE; HORMESIS; HUMAN; INJURY SEVERITY; INTRACRANIAL PRESSURE; LIPID PEROXIDATION; NECROSIS; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NITROSATIVE STRESS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RESPIRATORY CHAIN; REVIEW; TRAUMATIC BRAIN INJURY;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN INJURIES; DNA DAMAGE; FREE RADICALS; HUMANS; LIPID PEROXIDATION; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOREDUCTASES; SIRTUINS;

EID: 84882712899     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4981     Document Type: Review

References (171)

1. Ahn MJ, Sherwood ER, Prough DS, Lin CY, and DeWitt DS. The effects of traumatic brain injury on cerebral blood flow and brain tissue nitric oxide levels and cytokine expression. J Neurotrauma 21: 1431-1442, 2004.
2. Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, Sasaki M, Klaus JA, Otsuka T, Zhang Z, Koehler RC, Hurn PD, Poirier GG, Dawson VL, and Dawson TM. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc Natl Acad Sci U S A 103: 18308-18313, 2006.
3. Aoyama N, Katayama Y, Kawamata T, Maeda T, Mori T, Yamamoto T, Kikuchi T, and Uwahodo Y. Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat. Brain Res 934: 117-124, 2002.
4. Arciniegas DB. Addressing neuropsychiatric disturbances during rehabilitation after traumatic brain injury: current and future methods. Dialogues Clin Neurosci 13: 325-345, 2011.
5. Balch WE, Morimoto RI, Dillin A, and Kelly JW. Adapting proteostasis for disease intervention. Science 319: 916-919, 2008.
6. Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas JS, Ye X, Leong KW, Dewhirst MW, Vujaskovic Z, Benov L, and Spasojevic I. Diverse functions of cationic Mn(III) Nsubstituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med 51: 1035-1053, 2011.
7. Bayir H, Kagan VE, Borisenko GG, Tyurina YY, Janesko KL, Vagni VA, Billiar TR, Williams DL, and Kochanek PM. Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS. J Cereb Blood Flow Metab 25: 673-684, 2005.
8. Bayir H, Kagan VE, Clark RS, Janesko-Feldman K, Rafikov R, Huang Z, Zhang X, Vagni V, Billiar TR, and Kochanek PM. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Cereb Blood Flow Metab 101: 168-181, 2007.
9. Bayir H, Kagan VE, Tyurina YY, Tyurin V, Ruppel RA, Adelson PD, Graham SH, Janesko K, Clark RS, and Kochanek PM. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatric Res 51: 571-578, 2002.
10. Bayir H, Kochanek PM, Liu SX, Arroyo A, Osipov A, Jiang J, Wisniewski S, Adelson PD, Graham SH, and Kagan VE. Increased S-nitrosothiols and S-nitrosoalbumin in cerebrospinal fluid after severe traumatic brain injury in infants and children: indirect association with intracranial pressure. J Cereb Blood Flow Metab 23: 51-61, 2003.
11. Beaumont A, Marmarou A, Czigner A, Yamamoto M, Demetriadou K, Shirotani T, Marmarou C, and Dunbar J. The impact-acceleration model of head injury: injury severity predicts motor and cognitive performance after trauma. Neurol Res 21: 742-754, 1999.
12. Besson VC, Croci N, Boulu RG, Plotkine M, and Marchand-Verrecchia C. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat. Brain Res 989: 58-66, 2003.
13. Bhakat KK, Mokkapati SK, Boldogh I, Hazra TK, and Mitra S. Acetylation of human 8-oxoguanine-DNA glycosylase by p300 and its role in 8-oxoguanine repair in vivo. Mol Cell Biol 26: 1654-1665, 2006.
14. Bohr V, Anson RM, Mazur S, and Dianov G. Oxidative DNA damage processing and changes with aging. Toxicol Lett 102-103: 47-52, 1998.
15. Boiteux S, Gellon L, and Guibourt N. Repair of 8-oxoguanine in Saccharomyces cerevisiae: interplay of DNA repair and replication mechanisms. Free Radic Biol Med 32: 1244-1253, 2002.
16. Boldogh I, Hajas G, Aguilera-Aguirre L, Hegde ML, Radak Z, Bacsi A, Sur S, Hazra TK, and Mitra S. Activation of ras signaling pathway by 8-oxoguanine DNA glycosylase bound to its excision product, 8-oxoguanine. J Biol Chem 287: 20769-20773, 2012.
17. Boulton SJ and Jackson SP. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J 17: 1819-1828, 1998.
18. Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, and Grant R. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PloS One 6: e19194, 2011.
19. Brignull HR, Morley JF, and Morimoto RI. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv Exp Med Biol 594: 167-189, 2007.
20. Broadley SA and Hartl FU. The role of molecular chaperones in human misfolding diseases. FEBS Lett 583: 2647-2653, 2009.
21. Bruns J Jr. and Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia 44 Suppl 10: 2-10, 2003.
22. Calabrese EJ. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications. Crit Rev Toxicol 38: 557-577, 2008.
23. Calabrese EJ. Hormesis and medicine. Br J Clin Pharmacol 66: 594-617, 2008.
24. Calabrese EJ. Neuroscience and hormesis: overview and general findings. Crit Rev Toxicol 38: 249-252, 2008.
25. Calabrese EJ. Pain and u-shaped dose responses: occurrence, mechanisms, and clinical implications. Crit Rev Toxicol 38: 579-590, 2008.
26. Calabrese EJ. Pharmacological enhancement of neuronal survival. Crit Rev Toxicol 38: 349-389, 2008.
27. Calabrese EJ and Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol 43: 175-197, 2003.
28. Calabrese EJ and Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol 202: 289-301, 2005.
29. Calabrese EJ and Blain RB. The hormesis database: the occurrence of hormetic dose responses in the toxicological literature. Regul Toxicol Pharmacol 61: 73-81, 2011.
30. Calabrese EJ and Mattson MP. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal 5: 25-38, 2011.
31. Calabrese V, Colombrita C, Sultana R, Scapagnini G, Calvani M, Butterfield DA, and Stella AM. Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function. Antioxid Redox Signal 8: 404-416, 2006.
32. Calabrese V, Cornelius C, Dinkova-Kostova AT, and Calabrese EJ. Vitagenes, cellular stress response, and acetylcarnitine: relevance to hormesis. Front Biosci 35: 146-160, 2009.
33. Calabrese V, Cornelius C, Mancuso C, Barone E, Calafato S, Bates T, Rizzarelli E, and Kostova AT. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front Biosci 14: 376-397, 2009.
34. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, and Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33: 2444-2471, 2008.
35. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, and Butterfield DA. Nitric oxide in cell survival: a janus molecule. Antioxid Redox Signal 11: 2717-2739, 2009.
36. Calabrese V, Guagliano E, Sapienza M, Panebianco M, Calafato S, Puleo E, Pennisi G, Mancuso C, Butterfield DA, and Stella AG. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Res 32: 757-773, 2007.
37. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, and Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8: 766-775, 2007.
38. Calabrese V, Mancuso C, Ravagna A, Perluigi M, Cini C, De Marco C, Butterfield DA, and Stella AM. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. J Neurochem 101: 709-717, 2007.
39. Calderwood SK, Murshid A, and Prince T. The shock of aging: molecular chaperones and the heat shock response in longevity and aging-a mini-review. Gerontology 55: 550-558, 2009.
40. Cardenas A, Moro MA, Hurtado O, Leza JC, and Lizasoain I. Dual role of nitric oxide in adult neurogenesis. Brain Res Rev 50: 1-6, 2005.
41. Cardozo-Pelaez F, Stedeford TJ, Brooks PJ, Song S, and Sanchez-Ramos JR. Effects of diethylmaleate on DNA damage and repair in the mouse brain. Free Radic Biol Med 33: 292-298, 2002.
42. Caro P, Gomez J, Sanchez I, Naudi A, Ayala V, Lopez-Torres M, Pamplona R, and Barja G. Forty percent methionine restriction decreases mitochondrial oxygen radical production and leak at complex I during forward electron flow and lowers oxidative damage to proteins and mitochondrial DNA in rat kidney and brain mitochondria. Rejuvenation Res 12: 421-434, 2009.
43. Cernak I, Savic VJ, Kotur J, Prokic V, Veljovic M, and Grbovic D. Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J Neurotrauma 17: 53-68, 2000.
44. Chen G, Zhang S, Shi J, Ai J, Qi M, and Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NFkappaB pathway. Exp Neurol 216: 398-406, 2009.
45. Chen J and Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 3: 466-473, 2006.
46. Chen XR, Besson VC, Palmier B, Garcia Y, Plotkine M, and Marchand-Leroux C. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J Neurotrauma 24: 1119-1131, 2007.
47. Cherian L, Chacko G, Goodman JC, and Robertson CS. Cerebral hemodynamic effects of phenylephrine and L-arginine after cortical impact injury. Crit Care Med 27: 2512-2517, 1999.
48. Cook LG, Chapman SB, and Levin HS. Self-regulation abilities in children with severe traumatic brain injury: a preliminary investigation of naturalistic action. NeuroRehabilitation 23: 467-475, 2008.
49. Coppede F and Migliore L. Evidence linking genetics, environment, and epigenetics to impaired DNA repair in Alzheimer's disease. J Alzheimers Dis 20: 953-966, 2010.
50. Cosi C, SuzukiH,MilaniD, Facci L, MenegazziM,VantiniG, Kanai Y, and Skaper SD. Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 39: 38-46, 1994.
51. Cucchiara B and Kasner SE. Use of statins in CNS disorders. J Neurol Sci 187: 81-89, 2001.
52. Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res 52: 72-82, 2005.
53. De Marchis S, Modena C, Peretto P, Giffard C, and Fasolo A. Carnosine-like immunoreactivity in the central nervous system of rats during postnatal development. J Comp Neurol 426: 378-390, 2000.
54. DeKosky ST, Abrahamson EE, Taffe KM, Dixon CE, Kochanek PM, and Ikonomovic MD. Effects of post-injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapies. J Neurochem 90: 998-1004, 2004.
55. Delanty N, Vaughan CJ, and Sheehy N. Statins and neuroprotection. Expert Opin Investig Drugs 10: 1847-1853, 2001.
56. Dizdaroglu M, Jaruga P, Birincioglu M, and Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 32: 1102-1115, 2002.
57. Dizdaroglu M, Kirkali G, and Jaruga P. Formamidopyrimidines in DNA: mechanisms of formation, repair, and biological effects. Free Radic Biol Med 45: 1610-1621, 2008.
58. Donkin JJ and Vink R. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments. Curr Opin Neurol 23: 293-299, 2010.
59. Fabian RH, Dewitt DS, and Kent TA. The 21-aminosteroid U-74389G reduces cerebral superoxide anion concentration following fluid percussion injury of the brain. J Neurotrauma 15: 433-440, 1998.
60. Farkas O and Povlishock JT. Cellular and subcellular change evoked by diffuse traumatic brain injury: a complex web of change extending far beyond focal damage. Prog Brain Res 161: 43-59, 2007.
61. Fink EL, Lai Y, Zhang X, Janesko-Feldman K, Adelson PD, Szabo C, Berger RP, Sarnaik AA, Kochanek PM, and Clark RS. Quantification of poly(ADP-ribose)-modified proteins in cerebrospinal fluid from infants and children after traumatic brain injury. J Cereb Blood Flow Metab 28: 1523-1529, 2008.
62. Foster M and Tilse C. Referral to rehabilitation following traumatic brain injury: a model for understanding inequities in access. Soc Sci Med 56: 2201-2210, 2003.
63. Friedman SD, Brooks WM, Jung RE, Chiulli SJ, Sloan JH, Montoya BT, Hart BL, and Yeo RA. Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology 52: 1384-1391, 1999.
64. Gahm C, Holmin S, and Mathiesen T. Temporal profiles and cellular sources of three nitric oxide synthase isoforms in the brain after experimental contusion. Neurosurgery 46: 169-177, 2000.
65. Gaulke LJ, Horner PJ, Fink AJ, McNamara CL, and Hicks RR. Environmental enrichment increases progenitor cell survival in the dentate gyrus following lateral fluid percussion injury. Brain Res Mol Brain Res 141: 138-150, 2005.
66. Genovese T and Cuzzocrea S. Role of free radicals and poly(ADP-ribose)polymerase-1 in the development of spinal cord injury: new potential therapeutic targets. Curr Med Chem 15: 477-487, 2008.
67. Gottlieb E and Vousden KH. p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol 2: a001040, 2010.
68. Gredilla R, Weissman L, Yang JL, Bohr VA, and Stevnsner T. Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer's disease. Neurobiol Aging 33: 694-707, 2012.
69. Hall ED, Yonkers PA, McCall JM, and Braughler JM. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg 68: 456-461, 1988.
70. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 46: 531-542, 2009.
71. Hamby AM, Suh SW, Kauppinen TM, and Swanson RA. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemiareperfusion. Stroke 38: 632-636, 2007.
72. Hamm RJ, Temple MD, Pike BR, and Ellis EF. The effect of postinjury administration of polyethylene glycol-conjugated superoxide dismutase (pegorgotein, Dismutec) or lidocaine on behavioral function following fluid-percussion brain injury in rats. J Neurotrauma 13: 325-332, 1996.
73. Hassa PO, Haenni SS, Elser M, and Hottiger MO. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70: 789-829, 2006.
74. Hazra TK, Hill JW, Izumi T, and Mitra S. Multiple DNA glycosylases for repair of 8-oxoguanine and their potential in vivo functions. Prog Nucleic Acid Res Mol Biol 68: 193-205, 2001.
75. Hipkiss AR. Energy metabolism, proteotoxic stress and age-related dysfunction-protection by carnosine. Mol Aspects Med 32: 267-278, 2011.
76. Hlatky R, Furuya Y, Valadka AB, Goodman JC, and Robertson CS. Comparison of microdialysate arginine and glutamate levels in severely head-injured patient. Acta Neurochir Suppl 81: 347-349, 2002.
77. Hlatky R, Goodman JC, Valadka AB, and Robertson CS. Role of nitric oxide in cerebral blood flow abnormalities after traumatic brain injury. J Cereb Blood Flow Metab 23: 582-588, 2003.
78. Hlatky R, Lui H, Cherian L, Goodman JC, O'Brien WE, Contant CF, and Robertson CS. The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice. J Neurotrauma 20: 995-1006, 2003.
79. Hou Z, Luo W, Sun X, Hao S, Zhang Y, Xu F, Wang Z, and Liu B. Hydrogen-rich saline protects against oxidative damage and cognitive deficits after mild traumatic brain injury. Brain Res Bull 88: 560-565, 2012.
80. Houtkooper RH, Pirinen E, and Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13: 225-238, 2012.
81. Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36: 1199-1207, 2004.
82. Julien C, Tremblay C, Emond V, Lebbadi M, Salem N, Jr., Bennett DA, and Calon F. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68: 48-58, 2009.
83. Juurlink BH and Paterson PG. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21: 309-334, 1998.
84. Kaneko T, Tahara S, and Matsuo M. Non-linear accumulation of 8-hydroxy-2′-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat Res 316: 277-285, 1996.
85. Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, Bar-Joseph Z, and Cohen HY. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483: 218-221, 2012.
86. Kanvah S, Joseph J, Schuster GB, Barnett RN, Cleveland CL, and Landman U. Oxidation of DNA: damage to nucleobases. Acc Chem Res 43: 280-287, 2010.
87. Kauppinen TM. Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease. Neurochem Int 50: 954-958, 2007.
88. Kauppinen TM, Suh SW, Berman AE, Hamby AM, and Swanson RA. Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J Cereb Blood Flow Metab 29: 820-829, 2009.
89. Kauppinen TM and Swanson RA. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol 174: 2288-2296, 2005.
90. Koltai E, Zhao Z, Lacza L, Cselenyak A, Vacz G, Nyakas C, Boldogh I, Ichinoseki-Sekine N, and Radak Z. Combined exercise and IGF-1 supplementation induces neurogenesis in old rats, but do not attenuate age-associated DNA damage. Rejuvenation Res 14: 585-596, 2011.
91. Kontos HA and Povlishock JT. Oxygen radicals in brain injury. Cent Nerv Syst Trauma 3: 257-263, 1986.
92. Kontos HA and Wei EP. Superoxide production in experimental brain injury. J Neurosurg 64: 803-807, 1986.
93. Kushner D. Mild traumatic brain injury: toward understanding manifestations and treatment. Arch Intern Med 158: 1617-1624, 1998.
94. Ladelfa MF, Toledo MF, Laiseca JE, and Monte M. Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production. Antioxid Redox Signal 15: 1749-1761, 2011.
95. LaPlaca MC, Raghupathi R, Verma A, Pieper AA, Saatman KE, Snyder SH, and McIntosh TK. Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. J Neurochem 73: 205-213, 1999.
96. Lenaz G. Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Exp Med Biol 942: 93-136, 2012.
97. Lewen A, Skoglosa Y, Clausen F, Marklund N, Chan PH, Lindholm D, and Hillered L. Paradoxical increase in neuronal DNA fragmentation after neuroprotective free radical scavenger treatment in experimental traumatic brain injury. J Cereb Blood Flow Metab 21: 344-350, 2001.
98. Li H, Swiercz R, and Englander EW. Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway: implications of pathologic iron overload in the brain on integrity of neuronal DNA. J Neurochem 110: 1774-1783, 2009.
99. Lin Y, Han Y, Xu J, Cao L, Gao J, Xie N, Zhao X, Jiang H, and Chi Z. Mitochondrial DNA damage and the involvement of antioxidant defense and repair system in hippocampi of rats with chronic seizures. Cell Mol Neurobiol 30: 947-954, 2010.
100. Liu D, Gharavi R, Pitta M, Gleichmann M, and Mattson MP. Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med 11: 28-42, 2009.
101. Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, and Jafarian-Tehrani M. Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 50: 182-190, 2006.
102. Lu D, Mahmood A, Qu C, Goussev A, Schallert T, and Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma 22: 1011-1017, 2005.
103. Lu D, Mahmood A, Zhang R, and Copp M. Upregulation of neurogenesis and reduction in functional deficits following administration of DEtA/NONOate, a nitric oxide donor, after traumatic brain injury in rats. J Neurosurg 99: 351-361, 2003.
104. Macario AJ and Conway de Macario E. Molecular chaperones: multiple functions, pathologies, and potential applications. Front Biosci 12: 2588-2600, 2007.
105. Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A, Poirier GG, Wang ZQ, Dawson TM, and Dawson VL. NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci 20: 8005-8011, 2000.
106. Masutani M, Nozaki T, Nakamoto K, Nakagama H, Suzuki H, Kusuoka O, Tsutsumi M, and Sugimura T. The response of Parp knockout mice against DNA damaging agents. Mutat Res 462: 159-166, 2000.
107. Mates JM, Segura JA, Alonso FJ, and Marquez J. Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms. Free Radic Biol Med 49: 1328-1341, 2010.
108. Mattson MP, Duan W, Chan SL, Cheng A, Haughey N, Gary DS, Guo Z, Lee J, and Furukawa K. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol Aging 23: 695-705, 2002.
109. Mattson MP, Goodman Y, Luo H, Fu W, and Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49: 681-697, 1997.
110. Mattson MP, Son TG, and Camandola S. Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response 5: 174-186, 2007.
111. Matus S, Castillo K, and Hetz C. Hormesis: Protecting neurons against cellular stress in Parkinson disease. Autophagy 8: 997-1001, 2012.
112. McConeghy KW, Hatton J, Hughes L, and Cook AM. A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs 26: 613-636, 2012.
113. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, and Beal MF. Oxidative damage to mitochondrial DNA shows marked agedependent increases in human brain. Ann Neurol 34: 609-616, 1993.
114. Mesenge C, Charriaut-Marlangue C, Verrecchia C, Allix M, Boulu RR, and Plotkine M. Reduction of tyrosine nitration after N(omega)-nitro-L-arginine- methylester treatment of mice with traumatic brain injury. Eur J Pharmacol 353: 53-57, 1998.
115. Mesenge C, Margaill I, Verrecchia C, Allix M, Boulu RG, and Plotkine M. Protective effect of melatonin in a model of traumatic brain injury in mice. J Pineal Res 25: 41-46, 1998.
116. Mesenge C, Verrecchia C, Allix M, Boulu RR, and Plotkine M. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J Neurotrauma 13: 11-16, 1996.
117. Mikawa S, Kinouchi H, Kamii H, Gobbel GT, Chen SF, Carlson E, Epstein CJ, and Chan PH. Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J Neurosurg 85: 885-891, 1996.
118. Mills KD, Sinclair DA, and Guarente L. MEC1-dependent redistribution of the Sir3 silencing protein from telomeres to DNA double-strand breaks. Cell 97: 609-620, 1999.
119. Morimoto RI. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12: 3788-3796, 1998.
120. Morimoto RI. Stress, aging, and neurodegenerative disease. N Engl J Med 355: 2254-2255, 2006.
121. Morimoto RI and Santoro MG. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 16: 833-838, 1998.
122. Nakabeppu Y, Tsuchimoto D, Furuichi M, and Sakumi K. The defense mechanisms in mammalian cells against oxidative damage in nucleic acids and their involvement in the suppression of mutagenesis and cell death. Free Radic Res 38: 423-429, 2004.
123. Nakamoto H, Kaneko T, Tahara S, Hayashi E, Naito H, Radak Z, and Goto S. Regular exercise reduces 8-oxodG in the nuclear and mitochondrial DNA and modulates the DNA repair activity in the liver of old rats. Exp Gerontol 42: 287-295, 2007.
124. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, Bullock MR, Choi SC, Clifton GL, Contant CF, Coplin WM, Dietrich WD, Ghajar J, Grady SM, Grossman RG, Hall ED, Heetderks W, Hovda DA, Jallo J, Katz RL, Knoller N, Kochanek PM, Maas AI, Majde J, Marion DW, Marmarou A, Marshall LF, McIntosh TK, Miller E, Mohberg N, Muizelaar JP, Pitts LH, Quinn P, Riesenfeld G, Robertson CS, Strauss KI, Teasdale G, Temkin N, Tuma R, Wade C, Walker MD, Weinrich M, Whyte J, Wilberger J, Young AB, and Yurkewicz L. Clinical trials in head injury. J Neurotrauma 19: 503-557, 2002.
125. Nishimura S. Involvement of mammalian OGG1(MMH) in excision of the 8-hydroxyguanine residue in DNA. Free Radic Biol Med 32: 813-821, 2002.
126. Nishimura S. Mammalian Ogg1/Mmh gene plays a major role in repair of the 8-hydroxyguanine lesion in DNA. Prog Nucleic Acid Res Mol Biol 68: 107-123, 2001.
127. North BJ, Marshall BL, Borra MT, Denu JM, and Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+ -dependent tubulin deacetylase. Mol Cell 11: 437-444, 2003.
128. Obulesu M, and Rao DM. DNA damage and impairment of DNA repair in Alzheimer's disease. Int J Neurosci 120: 397-403, 2010.
129. Ochoa JJ, Pamplona R, Ramirez-Tortosa MC, Granados-Principal S, Perez-Lopez P, Naudi A, Portero-Otin M, Lopez-Frias M, Battino M, and Quiles JL. Age-related changes in brain mitochondrial DNA deletion and oxidative stress are differentially modulated by dietary fat type and coenzyme Q. Free Radic Biol Med 50: 1053-1064, 2011.
130. Okatani Y, Wakatsuki A, and Kaneda C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 28: 89-96, 2000.
131. Pacher P, Beckman JS, and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424, 2007.
132. Pineda JA, Aono M, Sheng H, Lynch J, Wellons JC, Laskowitz DT, Pearlstein RD, Bowler R, Crapo J, and Warner DS. Extracellular superoxide dismutase overexpression improves behavioral outcome from closed head injury in the mouse. J Neurotrauma 18: 625-634, 2001.
133. Povlishock JT, and Kontos HA. The role of oxygen radicals in the pathobiology of traumatic brain injury. Human Cell 5: 345-353, 1992.
134. Puzzo D, Privitera L, and Palmeri A. Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory. Neurobiol Aging 33: 1484.e1415-e1424, 2012.
135. Radak Z and Boldogh I. 8-Oxo-7,8-dihydroguanine: links to gene expression, aging, and defense against oxidative stress. Free Radic Biol Med 49: 587-596, 2010.
136. Radak Z, Bori Z, Koltai E, Fatouros IG, Jamurtas AZ, Douroudos, II, Terzis G, Nikolaidis MG, Chatzinikolaou A, Sovatzidis A, Kumagai S, Naito H, and Boldogh I. Agedependent changes in 8-oxoguanine-DNA glycosylase activity are modulated by adaptive responses to physical exercise in human skeletal muscle. Free Radic Biol Med 51: 417-423, 2011.
137. Ralser M, Michel S, and Breitenbach M. Sirtuins as regulators of the yeast metabolic network. Front Pharmacol 3: 32, 2012.
138. Rosenfeld JV and Ford NL. Bomb blast, mild traumatic brain injury and psychiatric morbidity: a review. Injury 41: 437-443, 2010.
139. Sadrzadeh SM and Eaton JW. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 82: 1510-1515, 1988.
140. Satchell MA, Zhang X, Kochanek PM, Dixon CE, Jenkins LW, Melick J, Szabo C, and Clark RS. A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma. J Neurochem 85: 697-708, 2003.
141. Schmitz C, Axmacher B, Zunker U, and Korr H. Age-related changes ofDNArepair and mitochondrialDNAsynthesis in the mouse brain. Acta Neuropathol 97: 71-81, 1999.
142. Schreiber V, Dantzer F, Ame JC, and de Murcia G. Poly(-ADP-ribose): novel functions for an old molecule. Nat Rev 7: 517-528, 2006.
143. Sies H and Menck CF. Singlet oxygen induced DNA damage. Mutat Res 275: 367-375, 1992.
144. Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, and Vagnozzi R. N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. J Neurotrauma 18: 977-991, 2001.
145. Sinz EH, Kochanek PM, Dixon CE, Clark RS, Carcillo JA, Schiding JK, Chen M, Wisniewski SR, Carlos TM, Williams D, DeKosky ST, Watkins SC, Marion DW, and Billiar TR. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest 104: 647-656, 1999.
146. Spina-Purrello V, Giliberto S, Barresi V, Nicoletti VG, Giuffrida Stella AM, and Rizzarelli E. Modulation of PARP-1 and PARP-2 expression by L-carnosine and trehalose after LPS and INFgamma-induced oxidative stress. Neurochem Res 35: 2144-2153, 2010.
147. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, and Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397-408, 2006.
148. Steiner J, Rafols D, Park HK, Katar MS, Rafols JA, and Petrov T. Attenuation of iNOS mRNA exacerbates hypoperfusion and upregulates endothelin-1 expression in hippocampus and cortex after brain trauma. Nitric Oxide 10: 162-169, 2004.
149. Stoffel M, Rinecker M, Plesnila N, Eriskat J, and Baethmann A. Role of nitric oxide in the secondary expansion of a cortical brain lesion from cold injury. J Neurotrauma 18: 425-434, 2001.
150. Swain U and Subba Rao K. Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging. Mech Ageing Dev 132: 374-381, 2011.
151. Tavazzi B, Vagnozzi R, Di Pierro D, Amorini AM, Fazzina G, Signoretti S, Marmarou A, Caruso I, and Lazzarino G. Ion-pairing high-performance liquid chromatographic method for the detection of N-acetylaspartate and Nacetylglutamate in cerebral tissue extracts. Anal Biochem 277: 104-108, 2000.
152. Toczylowska B, Chalimoniuk M, Wodowska M, and Mayzner-Zawadzk E. Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury. Brain Res 1104: 183-189, 2006.
153. Toulmond S and Rothwell NJ. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 671: 261-266, 1995.
154. Trott A, West JD, Klaic L, Westerheide SD, Silverman RB, Morimoto RI, and Morano KA. Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol Biol Cell 19: 1104-1112, 2008.
155. Vendelbo MH and Nair KS. Mitochondrial longevity pathways. Biochim Biophys Acta 1813: 634-644, 2011.
156. von Sonntag C. The Chemical Basis of Radiation Biology. New York: Taylor and Francis; 1987.
157. Wada K, Chatzipanteli K, Busto R, and Dietrich WD. Effects of L-NAME and 7-NI on NOS catalytic activity and behavioral outcome after traumatic brain injury in the rat. J Neurotrauma 16: 203-212, 1999.
158. Wada K, Chatzipanteli K, Kraydieh S, Busto R, and Dietrich WD. Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43: 1427-1436, 1998.
159. Wallace SS. Biological consequences of free radical-damaged DNA bases. Free Radic Biol Med 33: 1-14, 2002.
160. Wallis RA, Panizzon KL, and Girard JM. Traumatic neuroprotection with inhibitors of nitric oxide and ADPribosylation. Brain Res 710: 169-177, 1996.
161. Wang KK, Larner SF, Robinson G, and Hayes RL. Neuroprotection targets after traumatic brain injury. Curr Opin Neurol 19: 514-519, 2006.
162. Wang X and Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2: 12, 2010.
163. Westerheide SD, Anckar J, Stevens SM, Jr., Sistonen L, and Morimoto RI. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323: 1063-1066, 2009.
164. Whalen MJ, Clark RS, Dixon CE, Robichaud P, Marion DW, Vagni V, Graham SH, Virag L, Hasko G, Stachlewitz R, Szabo C, and Kochanek PM. Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 19: 835-842, 1999.
165. Wible EF and Laskowitz DT. Statins in traumatic brain injury. Neurotherapeutics 7: 62-73, 2010.
166. Wieloch T and Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 16: 258-264, 2006.
167. Yamamori T, DeRicco J, Naqvi A, Hoffman TA, Mattagajasingh I, Kasuno K, Jung SB, Kim CS, and Irani K. SIRT1 deacetylates APE1 and regulates cellular base excision repair. Nucleic Acids Res 38: 832-845, 2010.
168. Yi JH and Hazell AS. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int 48: 394-403, 2006.
169. Zaleska MM and Floyd RA. Regional lipid peroxidation in rat brain in vitro: possible role of endogenous iron. Neurochem Res 10: 397-410, 1985.
170. Zhang R, Zhang L, Zhang Z, Wang Y, Lu M, Lapointe M, and Chopp M. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann Neurol 50: 602-611, 2001.
171. Ziebell JM and Morganti-Kossmann MC. Involvement of pro-and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7: 22-30, 2010.